España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
BridgeBio Pharma
BBIO
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$25.00
0.09
0.36%
At Close: -
$25.60
0.6
2.40%
After Hours: 4:58 PM EDT
15 minutes delayed
Get Report
Watch
BridgeBio Pharma (BBIO) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for BridgeBio Pharma (NASDAQ:BBIO) Stock
BridgeBio Pharma Stock (NASDAQ: BBIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 01, 2024
Cantor Fitzgerald Reiterates Overweight on Br...
Benzinga Newsdesk
Tuesday, June 25, 2024
B of A Securities Maintains Buy on BridgeBio ...
Benzinga Newsdesk
Monday, June 24, 2024
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Thursday, June 20, 2024
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Tuesday, June 18, 2024
Bridgebio Pharma Announced It Has Surpassed I...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Tuesday, June 04, 2024
BridgeBio Pharma Shares One Year Data From Dwarfism Candidate
Vandana Singh
Why BridgeBio Pharma Stock Is Trading Lower Tuesday
Dylan Berman
BridgeBio Pharma shares are trading lower aft...
Benzinga Newsdesk
BridgeBio Pharma Reports Phase 2 Results for ...
Benzinga Newsdesk
Thursday, May 30, 2024
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Wednesday, May 29, 2024
BridgeBio Pharma Announces Results Of Five Ne...
Benzinga Newsdesk
Tuesday, May 28, 2024
Cantor Fitzgerald Reiterates Overweight on Br...
Benzinga Newsdesk
UBS Maintains Buy on BridgeBio Pharma, Lowers...
Benzinga Newsdesk
Friday, May 24, 2024
BridgeBio Pharma Says It Will Present Additio...
Benzinga Newsdesk
Monday, May 20, 2024
HC Wainwright & Co. Maintains Buy on BridgeBi...
Benzinga Newsdesk
Thursday, May 16, 2024
BridgeBio Pharma's Options: A Look at What the Big Money is Thinking
Benzinga Insights
Tuesday, May 14, 2024
Evercore ISI Group Initiates Coverage On Brid...
Benzinga Newsdesk
Monday, May 13, 2024
BridgeBio Pharma Presents Additional Data and...
Benzinga Newsdesk
Thursday, May 02, 2024
BridgeBio Launches BridgeBio Oncology Therape...
Benzinga Newsdesk
Monday, April 08, 2024
Reported Sunday, BridgeBio Pharma Presented R...
Benzinga Newsdesk
Wednesday, March 20, 2024
JP Morgan Maintains Overweight on BridgeBio P...
Benzinga Newsdesk
Tuesday, March 19, 2024
Cantor Fitzgerald Maintains Overweight on Bri...
Benzinga Newsdesk
Monday, March 11, 2024
Cantor Fitzgerald Maintains Overweight on Bri...
Benzinga Newsdesk
Wednesday, March 06, 2024
BridgeBio Pharma Prices Public Offering Of 8,...
Benzinga Newsdesk
Tuesday, March 05, 2024
BridgeBio Pharma shares are trading lower aft...
Benzinga Newsdesk
Mizuho Maintains Buy on BridgeBio Pharma, Low...
Benzinga Newsdesk
Monday, March 04, 2024
BridgeBio Pharma Announces Proposed Public Of...
Benzinga Newsdesk
What's Going On With BridgeBio Pharma Stock On Monday?
Vandana Singh
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
BridgeBio Pharma And Bayer Announce European ...
Benzinga Newsdesk
Thursday, February 22, 2024
Recap: BridgeBio Pharma Q4 Earnings
Benzinga Insights
BridgeBio Pharma Q4 EPS $(0.96) Misses $(0.91...
Benzinga Newsdesk
Thursday, February 15, 2024
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, February 07, 2024
BridgeBio, Kyowa Kirin Ink Partnership With A...
Benzinga Newsdesk
Monday, February 05, 2024
The FDA Has Bridgebio Pharma's New Drug Appli...
Benzinga Newsdesk
Friday, February 02, 2024
AstraZeneca's Results From Japan Phase 3 Tria...
Benzinga Newsdesk
Wednesday, January 31, 2024
BMO Capital Initiates Coverage On BridgeBio P...
Benzinga Newsdesk
Tuesday, January 30, 2024
Invitae Partners with BridgeBio Pharma to Har...
Benzinga Newsdesk
Monday, January 29, 2024
HC Wainwright & Co. Maintains Buy on BridgeBi...
Benzinga Newsdesk
Monday, January 22, 2024
Cantor Fitzgerald Reiterates Overweight on Br...
Benzinga Newsdesk
Thursday, January 18, 2024
BridgeBio Pharma shares are trading higher af...
Benzinga Newsdesk
BridgeBio Pharma Announced Strategic Financin...
Benzinga Newsdesk
Wednesday, January 10, 2024
BridgeBio Reports Publication Of Results From...
Benzinga Newsdesk
Wednesday, January 03, 2024
FDA Has Cleared BridgeBio Pharma's Investigat...
Benzinga Newsdesk
Wednesday, December 13, 2023
Bridgebio Pharma Has Dosed The First Child In...
Benzinga Newsdesk
Thursday, December 07, 2023
A Closer Look at BridgeBio Pharma's Options Market Dynamics
Benzinga Insights
Tuesday, December 05, 2023
BridgeBio Pharma Submits NDA For Acoramidis T...
Benzinga Newsdesk
Sunday, November 12, 2023
BridgeBio Pharma Presented Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloidosis Cardiomyopath
Charles Gross
Friday, November 10, 2023
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch